119 related articles for article (PubMed ID: 35110594)
1. Enhanced quantitative method for the diagnosis of grade 1 cardiac amyloidosis in
Mallón Araujo MDC; Abou Jokh Casas E; Abou Jokh Casas C; Aguiar Fernández P; Martínez Monzonís MA; Sopeña Pérez-Argüelles B; Pubul Núñez V
Sci Rep; 2022 Feb; 12(1):1740. PubMed ID: 35110594
[TBL] [Abstract][Full Text] [Related]
2. 99mTc-DPD scintigraphy in immunoglobulin light chain (AL) cardiac amyloidosis.
Quarta CC; Zheng J; Hutt D; Grigore SF; Manwani R; Sachchithanantham S; Mahmood SA; Whelan CJ; Fontana M; Martinez-Naharro A; Chacko L; Lachmann HJ; Gillmore JD; Rapezzi C; Hawkins PN; Wechalekar AD
Eur Heart J Cardiovasc Imaging; 2021 Oct; 22(11):1304-1311. PubMed ID: 34254119
[TBL] [Abstract][Full Text] [Related]
3. Low Sensitivity of Bone Scintigraphy in Detecting Phe64Leu Mutation-Related Transthyretin Cardiac Amyloidosis.
Musumeci MB; Cappelli F; Russo D; Tini G; Canepa M; Milandri A; Bonfiglioli R; Di Bella G; My F; Luigetti M; Grandis M; Autore C; Perlini S; Perfetto F; Rapezzi C
JACC Cardiovasc Imaging; 2020 Jun; 13(6):1314-1321. PubMed ID: 31864976
[TBL] [Abstract][Full Text] [Related]
4. Noninvasive etiologic diagnosis of cardiac amyloidosis using 99mTc-3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy.
Perugini E; Guidalotti PL; Salvi F; Cooke RM; Pettinato C; Riva L; Leone O; Farsad M; Ciliberti P; Bacchi-Reggiani L; Fallani F; Branzi A; Rapezzi C
J Am Coll Cardiol; 2005 Sep; 46(6):1076-84. PubMed ID: 16168294
[TBL] [Abstract][Full Text] [Related]
5. Role of cardiac scintigraphy with ⁹⁹mTc-DPD in the differentiation of cardiac amyloidosis subtype.
de Haro-del Moral FJ; Sánchez-Lajusticia A; Gómez-Bueno M; García-Pavía P; Salas-Antón C; Segovia-Cubero J
Rev Esp Cardiol (Engl Ed); 2012 May; 65(5):440-6. PubMed ID: 22464102
[TBL] [Abstract][Full Text] [Related]
6. The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis.
Morfino P; Aimo A; Giorgetti A; Genovesi D; Merlo M; Limongelli G; Castiglione V; Vergaro G; Emdin M
Heart Fail Clin; 2024 Jul; 20(3):307-316. PubMed ID: 38844301
[TBL] [Abstract][Full Text] [Related]
7. Cardiac denervation evidenced by MIBG occurs earlier than amyloid deposits detection by diphosphonate scintigraphy in TTR mutation carriers.
Piekarski E; Chequer R; Algalarrondo V; Eliahou L; Mahida B; Vigne J; Adams D; Slama MS; Le Guludec D; Rouzet F
Eur J Nucl Med Mol Imaging; 2018 Jul; 45(7):1108-1118. PubMed ID: 29511839
[TBL] [Abstract][Full Text] [Related]
8. Clinical and echocardiographic characteristics for differentiating between transthyretin-related and light-chain cardiac amyloidoses.
Mori M; An Y; Katayama O; Kitagawa T; Sasaki Y; Onaka T; Yonezawa A; Murata K; Yokota T; Ando K; Imada K
Ann Hematol; 2015 Nov; 94(11):1885-90. PubMed ID: 26251157
[TBL] [Abstract][Full Text] [Related]
9. Usefulness of (99m)Tc-HMDP scintigraphy for the etiologic diagnosis and prognosis of cardiac amyloidosis.
Galat A; Rosso J; Guellich A; Van Der Gucht A; Rappeneau S; Bodez D; Guendouz S; Tissot CM; Hittinger L; Dubois-Randé JL; Plante-Bordeneuve V; Itti E; Meignan M; Damy T
Amyloid; 2015; 22(4):210-20. PubMed ID: 26465835
[TBL] [Abstract][Full Text] [Related]
10. Prognostic utility of the Perugini grading of 99mTc-DPD scintigraphy in transthyretin (ATTR) amyloidosis and its relationship with skeletal muscle and soft tissue amyloid.
Hutt DF; Fontana M; Burniston M; Quigley AM; Petrie A; Ross JC; Page J; Martinez-Naharro A; Wechalekar AD; Lachmann HJ; Quarta CC; Rezk T; Mahmood S; Sachchithanantham S; Youngstein T; Whelan CJ; Lane T; Gilbertson JA; Rowczenio D; Hawkins PN; Gillmore JD
Eur Heart J Cardiovasc Imaging; 2017 Dec; 18(12):1344-1350. PubMed ID: 28159995
[TBL] [Abstract][Full Text] [Related]
11. 99mTc-DPD scintigraphy and SPECT/CT in patients with AL and ATTR type amyloidosis: Potential clinical implications.
Lee J; Kim K; Choi JO; Kim SJ; Jeon ES; Choi JY
Medicine (Baltimore); 2020 Jan; 99(4):e18905. PubMed ID: 31977903
[TBL] [Abstract][Full Text] [Related]
12. Lung uptake during 99mTc-hydroxymethylene diphosphonate scintigraphy in patient with TTR cardiac amyloidosis: An underestimated phenomenon.
Cappelli F; Gallini C; Costanzo EN; Tutino F; Ciaccio A; Vaggelli L; Bartolini S; Morini S; Martone R; Angelotti P; Frusconi S; Di Mario C; Perfetto F
Int J Cardiol; 2018 Mar; 254():346-350. PubMed ID: 29407121
[TBL] [Abstract][Full Text] [Related]
13. Spleen visualization in both TTR and AL amyloidosis during
Koutelou M; Tziomalos G; Chatzoglou V; Pappas N; Papanastasiou E; Chatzipavlidou V; Doumas A
Hell J Nucl Med; 2023; 26(2):140-144. PubMed ID: 37527050
[TBL] [Abstract][Full Text] [Related]
14. Negative bone scintigraphy in wild-type transthyretin cardiac amyloidosis.
Martini N; Rizzo S; Sarais C; Cipriani A
BMC Cardiovasc Disord; 2020 Oct; 20(1):466. PubMed ID: 33121442
[TBL] [Abstract][Full Text] [Related]
15. Diagnostic performance of imaging investigations in detecting and differentiating cardiac amyloidosis: a systematic review and meta-analysis.
Brownrigg J; Lorenzini M; Lumley M; Elliott P
ESC Heart Fail; 2019 Oct; 6(5):1041-1051. PubMed ID: 31487121
[TBL] [Abstract][Full Text] [Related]
16. Clinical Phenotyping of Transthyretin Cardiac Amyloidosis with Bone-Seeking Radiotracers in Heart Failure with Preserved Ejection Fraction.
Chen W; Ton VK; Dilsizian V
Curr Cardiol Rep; 2018 Mar; 20(4):23. PubMed ID: 29520480
[TBL] [Abstract][Full Text] [Related]
17. Etiology of amyloidosis determines myocardial 99mTc-DPD uptake in amyloidotic cardiomyopathy.
Longhi S; Bonfiglioli R; Obici L; Gagliardi C; Milandri A; Lorenzini M; Guidalotti PL; Merlini G; Rapezzi C
Clin Nucl Med; 2015 May; 40(5):446-7. PubMed ID: 25742226
[TBL] [Abstract][Full Text] [Related]
18. The Utility of
Moore PT; Burrage MK; Mackenzie E; Law WP; Korczyk D; Mollee P
Heart Lung Circ; 2017 Nov; 26(11):1183-1190. PubMed ID: 28256403
[TBL] [Abstract][Full Text] [Related]
19. The short and long-term characteristics and outcomes of patients with grade 1 myocardial uptake on cardiac scintigraphy.
Itzhaki Ben Zadok O; Ruhrman-Sahar N; Mats I; Vaxman I; Shiyovich A; Aviv Y; Vaturi M; Wiessman M; Shochat T; Kandinov I; Kornowski R; Hamdan A
ESC Heart Fail; 2023 Jun; 10(3):1666-1676. PubMed ID: 36799266
[TBL] [Abstract][Full Text] [Related]
20. Utility and limitations of 3,3-diphosphono-1,2-propanodicarboxylic acid scintigraphy in systemic amyloidosis.
Hutt DF; Quigley AM; Page J; Hall ML; Burniston M; Gopaul D; Lane T; Whelan CJ; Lachmann HJ; Gillmore JD; Hawkins PN; Wechalekar AD
Eur Heart J Cardiovasc Imaging; 2014 Nov; 15(11):1289-98. PubMed ID: 24939945
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
